Erratum: Universal Patterns of Selection in Cancer and Somatic Tissues (Cell (2017) 171(5) (1029–1041.e21) (S0092867417311364) (10.1016/j.cell.2017.09.042));Universal Patterns of Selection in Cancer and Somatic Tissues

Cell

Volumn 171, Issue 5, 2017, Pages 1029-1041.e21

  Martincorena, Iñigo ^a   Raine, Keiran M ^a   Gerstung, Moritz ^b   Dawson, Kevin J ^a   Haase, Kerstin ^c   Van Loo, Peter ^c,d   Davies, Helen ^a   Stratton, Michael R ^a   Campbell, Peter J ^a,e  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

^c THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

cancer; evolution; genomics; mutations; selection

Indexed keywords

ARTICLE; CANCER GENETICS; EXOME; GENE MUTATION; GENETIC SELECTION; GENOMICS; GERM LINE; HUMAN; HUMAN TISSUE; MISSENSE MUTATION; NEGATIVE SELECTION; NONSENSE MUTATION; POSITIVE SELECTION; PRIORITY JOURNAL; SOMATIC CELL; SYNONYMOUS MUTATION; TUMOR GENE; BIOLOGICAL MODEL; GENETICS; IMMUNOLOGY; INDEL MUTATION; MICROSATELLITE INSTABILITY; MUTATION RATE; NEOPLASM; PATHOLOGY; POINT MUTATION; SINGLE NUCLEOTIDE POLYMORPHISM;

HUMANS; INDEL MUTATION; MICROSATELLITE INSTABILITY; MODELS, GENETIC; MUTATION RATE; NEOPLASMS; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SELECTION, GENETIC;

EID: 85031823255     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2018.06.001     Document Type: Erratum

References (72)

1. Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., Aparicio, S.A., Behjati, S., Biankin, A.V., Bignell, G.R., Bolli, N., Borg, A., Børresen-Dale, A.L., et al. Australian Pancreatic Cancer Genome Initiative ICGC Breast Cancer Consortium ICGC MMML-Seq Consortium, ICGC PedBrain. Signatures of mutational processes in human cancer. Nature 500 (2013), 415–421.
2. Armitage, P., Doll, R., The age distribution of cancer and a multi-stage theory of carcinogenesis. Br. J. Cancer 8 (1954), 1–12.
3. Auton, A., Brooks, L.D., Durbin, R.M., Garrison, E.P., Kang, H.M., Korbel, J.O., Marchini, J.L., McCarthy, S., McVean, G.A., Abecasis, G.R., 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526 (2015), 68–74.
4. Beckman, R.A., Loeb, L.A., Negative clonal selection in tumor evolution. Genetics 171 (2005), 2123–2131.
5. Blokzijl, F., de Ligt, J., Jager, M., Sasselli, V., Roerink, S., Sasaki, N., Huch, M., Boymans, S., Kuijk, E., Prins, P., et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature 538 (2016), 260–264.
6. Blomen, V.A., Májek, P., Jae, L.T., Bigenzahn, J.W., Nieuwenhuis, J., Staring, J., Sacco, R., van Diemen, F.R., Olk, N., Stukalov, A., et al. Gene essentiality and synthetic lethality in haploid human cells. Science 350 (2015), 1092–1096.
7. Bolli, N., Avet-Loiseau, H., Wedge, D.C., Van Loo, P., Alexandrov, L.B., Martincorena, I., Dawson, K.J., Iorio, F., Nik-Zainal, S., Bignell, G.R., et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat. Commun., 5, 2014, 2997.
8. Cairns, J., Mutation selection and the natural history of cancer. Nature 255 (1975), 197–200.
9. Castro-Giner, F., Ratcliffe, P., Tomlinson, I., The mini-driver model of polygenic cancer evolution. Nat. Rev. Cancer 15 (2015), 680–685.
10. Church, D.N., Briggs, S.E., Palles, C., Domingo, E., Kearsey, S.J., Grimes, J.M., Gorman, M., Martin, L., Howarth, K.M., Hodgson, S.V., et al., NSECG Collaborators. DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer. Hum. Mol. Genet. 22 (2013), 2820–2828.
11. Dias, J., Van Nguyen, N., Georgiev, P., Gaub, A., Brettschneider, J., Cusack, S., Kadlec, J., Akhtar, A., Structural analysis of the KANSL1/WDR5/KANSL2 complex reveals that WDR5 is required for efficient assembly and chromatin targeting of the NSL complex. Genes Dev. 28 (2014), 929–942.
12. Forbes, S.A., Beare, D., Gunasekaran, P., Leung, K., Bindal, N., Boutselakis, H., Ding, M., Bamford, S., Cole, C., Ward, S., et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res. 43 (2015), D805–D811.
13. Fredriksson, N.J., Ny, L., Nilsson, J.A., Larsson, E., Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types. Nat. Genet. 46 (2014), 1258–1263.
14. Galloway, A., Saveliev, A., Łukasiak, S., Hodson, D.J., Bolland, D., Balmanno, K., Ahlfors, H., Monzón-Casanova, E., Mannurita, S.C., Bell, L.S., et al. RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence. Science 352 (2016), 453–459.
15. Gerstung, M., Papaemmanuil, E., Campbell, P.J., Subclonal variant calling with multiple samples and prior knowledge. Bioinformatics 30 (2014), 1198–1204.
16. Gerstung, M., Papaemmanuil, E., Martincorena, I., Bullinger, L., Gaidzik, V.I., Paschka, P., Heuser, M., Thol, F., Bolli, N., Ganly, P., et al. Precision oncology for acute myeloid leukemia using a knowledge bank approach. Nat. Genet. 49 (2017), 332–340.
17. Goldman, N., Yang, Z., A codon-based model of nucleotide substitution for protein-coding DNA sequences. Mol. Biol. Evol. 11 (1994), 725–736.
18. Greenman, C., Wooster, R., Futreal, P.A., Stratton, M.R., Easton, D.F., Statistical analysis of pathogenicity of somatic mutations in cancer. Genetics 173 (2006), 2187–2198.
19. Greenman, C., Stephens, P., Smith, R., Dalgliesh, G.L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., et al. Patterns of somatic mutation in human cancer genomes. Nature 446 (2007), 153–158.
20. Haradhvala, N.J., Polak, P., Stojanov, P., Covington, K.R., Shinbrot, E., Hess, J.M., Rheinbay, E., Kim, J., Maruvka, Y.E., Braunstein, L.Z., et al. Mutational strand asymmetries in cancer genomes reveal mechanisms of dna damage and repair. Cell 164 (2016), 538–549.
21. Hause, R.J., Pritchard, C.C., Shendure, J., Salipante, S.J., Classification and characterization of microsatellite instability across 18 cancer types. Nat. Med. 22 (2016), 1342–1350.
22. Jones, D., Raine, K.M., Davies, H., Tarpey, P.S., Butler, A.P., Teague, J.W., Nik-Zainal, S., Campbell, P.J., cgpCaVEManWrapper: simple execution of CaVEMan in order to detect somatic single nucleotide variants in NGS data. Curr. Protoc. Bioinformatics 56 (2016), 15.10.11–15.10.18.
23. Kandoth, C., McLellan, M.D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J.F., Wyczalkowski, M.A., et al. Mutational landscape and significance across 12 major cancer types. Nature 502 (2013), 333–339.
24. Kryazhimskiy, S., Plotkin, J.B., The population genetics of dN/dS. PLoS Genet., 4, 2008, e1000304.
25. Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., Ziller, M.J., et al., Roadmap Epigenomics Consortium. Integrative analysis of 111 reference human epigenomes. Nature 518 (2015), 317–330.
26. Lawrence, M.S., Stojanov, P., Polak, P., Kryukov, G.V., Cibulskis, K., Sivachenko, A., Carter, S.L., Stewart, C., Mermel, C.H., Roberts, S.A., et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499 (2013), 214–218.
27. Lawrence, M.S., Stojanov, P., Mermel, C.H., Robinson, J.T., Garraway, L.A., Golub, T.R., Meyerson, M., Gabriel, S.B., Lander, E.S., Getz, G., Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505 (2014), 495–501.
28. Lee, W., Jiang, Z., Liu, J., Haverty, P.M., Guan, Y., Stinson, J., Yue, P., Zhang, Y., Pant, K.P., Bhatt, D., et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 465 (2010), 473–477.
29. Lee, H., Palm, J., Grimes, S.M., Ji, H.P., The Cancer Genome Atlas Clinical Explorer: a web and mobile interface for identifying clinical-genomic driver associations. Genome Med., 7, 2015, 112.
30. Lek, M., Karczewski, K.J., Minikel, E.V., Samocha, K.E., Banks, E., Fennell, T., O'Donnell-Luria, A.H., Ware, J.S., Hill, A.J., Cummings, B.B., et al., Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536 (2016), 285–291.
31. Martincorena, I., Campbell, P.J., Somatic mutation in cancer and normal cells. Science 349 (2015), 1483–1489.
32. Martincorena, I., Seshasayee, A.S., Luscombe, N.M., Evidence of non-random mutation rates suggests an evolutionary risk management strategy. Nature 485 (2012), 95–98.
33. Martincorena, I., Roshan, A., Gerstung, M., Ellis, P., Van Loo, P., McLaren, S., Wedge, D.C., Fullam, A., Alexandrov, L.B., Tubio, J.M., et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348 (2015), 880–886.
34. McFarland, C.D., Korolev, K.S., Kryukov, G.V., Sunyaev, S.R., Mirny, L.A., Impact of deleterious passenger mutations on cancer progression. Proc. Natl. Acad. Sci. USA 110 (2013), 2910–2915.
35. McFarland, C.D., Mirny, L.A., Korolev, K.S., Tug-of-war between driver and passenger mutations in cancer and other adaptive processes. Proc. Natl. Acad. Sci. USA 111 (2014), 15138–15143.
36. McGranahan, N., Furness, A.J., Rosenthal, R., Ramskov, S., Lyngaa, R., Saini, S.K., Jamal-Hanjani, M., Wilson, G.A., Birkbak, N.J., Hiley, C.T., et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science 351 (2016), 1463–1469.
37. Miyata, T., Yasunaga, T., Molecular evolution of mRNA: a method for estimating evolutionary rates of synonymous and amino acid substitutions from homologous nucleotide sequences and its application. J. Mol. Evol. 16 (1980), 23–36.
38. Morley, A.A., The somatic mutation theory of ageing. Mutat. Res. 338 (1995), 19–23.
39. Mularoni, L., Sabarinathan, R., Deu-Pons, J., Gonzalez-Perez, A., López-Bigas, N., OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations. Genome Biol., 17, 2016, 128.
40. Nei, M., Gojobori, T., Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3 (1986), 418–426.
41. Nielsen, R., Yang, Z., Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148 (1998), 929–936.
42. Nik-Zainal, S., Davies, H., Staaf, J., Ramakrishna, M., Glodzik, D., Zou, X., Martincorena, I., Alexandrov, L.B., Martin, S., Wedge, D.C., et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534 (2016), 47–54.
43. Nordling, C.O., A new theory on cancer-inducing mechanism. Br. J. Cancer 7 (1953), 68–72.
44. Nowell, P.C., The clonal evolution of tumor cell populations. Science 194 (1976), 23–28.
45. Ostrow, S.L., Barshir, R., DeGregori, J., Yeger-Lotem, E., Hershberg, R., Cancer evolution is associated with pervasive positive selection on globally expressed genes. PLoS Genet., 10, 2014, e1004239.
46. Pleasance, E.D., Cheetham, R.K., Stephens, P.J., McBride, D.J., Humphray, S.J., Greenman, C.D., Varela, I., Lin, M.L., Ordóñez, G.R., Bignell, G.R., et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463 (2010), 191–196.
47. Pleasance, E.D., Stephens, P.J., O'Meara, S., McBride, D.J., Meynert, A., Jones, D., Lin, M.L., Beare, D., Lau, K.W., Greenman, C., et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463 (2010), 184–190.
48. Polak, P., Karlić, R., Koren, A., Thurman, R., Sandstrom, R., Lawrence, M., Reynolds, A., Rynes, E., Vlahoviček, K., Stamatoyannopoulos, J.A., Sunyaev, S.R., Cell-of-origin chromatin organization shapes the mutational landscape of cancer. Nature 518 (2015), 360–364.
49. Raine, K.M., Hinton, J., Butler, A.P., Teague, J.W., Davies, H., Tarpey, P., Nik-Zainal, S., Campbell, P.J., cgpPindel: identifying somatically acquired insertion and deletion events from paired end sequencing. Curr. Protoc. Bioinformatics 52 (2015), 15.17.11–15.17.12.
50. Raine, K.M., Van Loo, P., Wedge, D.C., Jones, D., Menzies, A., Butler, A.P., Teague, J.W., Tarpey, P., Nik-Zainal, S., Campbell, P.J., ascatNgs: Identifying somatically acquired copy-number alterations from whole-genome sequencing data. Curr Protoc Bioinformatics 56 (2016), 15.9.1–15.9.17.
51. Rajasagi, M., Shukla, S.A., Fritsch, E.F., Keskin, D.B., DeLuca, D., Carmona, E., Zhang, W., Sougnez, C., Cibulskis, K., Sidney, J., et al. Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia. Blood 124 (2014), 453–462.
52. Rayner, E., van Gool, I.C., Palles, C., Kearsey, S.E., Bosse, T., Tomlinson, I., Church, D.N., A panoply of errors: polymerase proofreading domain mutations in cancer. Nat. Rev. Cancer 16 (2016), 71–81.
53. Rooney, M.S., Shukla, S.A., Wu, C.J., Getz, G., Hacohen, N., Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160 (2015), 48–61.
54. Rubio-Perez, C., Tamborero, D., Schroeder, M.P., Antolín, A.A., Deu-Pons, J., Perez-Llamas, C., Mestres, J., Gonzalez-Perez, A., Lopez-Bigas, N., In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities. Cancer Cell 27 (2015), 382–396.
55. Schuster-Böckler, B., Lehner, B., Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature 488 (2012), 504–507.
56. Sherry, S.T., Ward, M.H., Kholodov, M., Baker, J., Phan, L., Smigielski, E.M., Sirotkin, K., dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29 (2001), 308–311.
57. Shlien, A., Campbell, B.B., de Borja, R., Alexandrov, L.B., Merico, D., Wedge, D., Van Loo, P., Tarpey, P.S., Coupland, P., Behjati, S., et al., Biallelic Mismatch Repair Deficiency Consortium. Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers. Nat. Genet. 47 (2015), 257–262.
58. Strønen, E., Toebes, M., Kelderman, S., van Buuren, M.M., Yang, W., van Rooij, N., Donia, M., Böschen, M.L., Lund-Johansen, F., Olweus, J., Schumacher, T.N., Targeting of cancer neoantigens with donor-derived T cell receptor repertoires. Science 352 (2016), 1337–1341.
59. Supek, F., Miñana, B., Valcárcel, J., Gabaldón, T., Lehner, B., Synonymous mutations frequently act as driver mutations in human cancers. Cell 156 (2014), 1324–1335.
60. Tomasetti, C., Marchionni, L., Nowak, M.A., Parmigiani, G., Vogelstein, B., Only three driver gene mutations are required for the development of lung and colorectal cancers. Proc. Natl. Acad. Sci. USA 112 (2015), 118–123.
61. Van den Eynden, J., Basu, S., Larsson, E., Somatic mutation patterns in hemizygous genomic regions unveil purifying selection during tumor evolution. PLoS Genet., 12, 2016, e1006506.
62. Van Loo, P., Nordgard, S.H., Lingjærde, O.C., Russnes, H.G., Rye, I.H., Sun, W., Weigman, V.J., Marynen, P., Zetterberg, A., Naume, B., et al. Allele-specific copy number analysis of tumors. Proc. Natl. Acad. Sci. USA 107 (2010), 16910–16915.
63. Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz, L.A. Jr., Kinzler, K.W., Cancer genome landscapes. Science 339 (2013), 1546–1558.
64. Wang, K., Li, M., Hadley, D., Liu, R., Glessner, J., Grant, S.F., Hakonarson, H., Bucan, M., PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 17 (2007), 1665–1674.
65. Welch, J.S., Ley, T.J., Link, D.C., Miller, C.A., Larson, D.E., Koboldt, D.C., Wartman, L.D., Lamprecht, T.L., Liu, F., Xia, J., et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 150 (2012), 264–278.
66. Wong, C.C., Martincorena, I., Rust, A.G., Rashid, M., Alifrangis, C., Alexandrov, L.B., Tiffen, J.C., Kober, C., Green, A.R., Massie, C.E., et al., Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium. Inactivating CUX1 mutations promote tumorigenesis. Nat. Genet. 46 (2014), 33–38.
67. Xie, M., Lu, C., Wang, J., McLellan, M.D., Johnson, K.J., Wendl, M.C., McMichael, J.F., Schmidt, H.K., Yellapantula, V., Miller, C.A., et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat. Med. 20 (2014), 1472–1478.
68. Yang, Z., PAML 4: phylogenetic analysis by maximum likelihood. Mol. Biol. Evol. 24 (2007), 1586–1591.
69. Yang, Z., Bielawski, J.P., Statistical methods for detecting molecular adaptation. Trends Ecol. Evol. 15 (2000), 496–503.
70. Yang, Z., Nielsen, R., Estimating synonymous and nonsynonymous substitution rates under realistic evolutionary models. Mol. Biol. Evol. 17 (2000), 32–43.
71. Yang, Z., Ro, S., Rannala, B., Likelihood models of somatic mutation and codon substitution in cancer genes. Genetics 165 (2003), 695–705.
72. Yates, L.R., Gerstung, M., Knappskog, S., Desmedt, C., Gundem, G., Van Loo, P., Aas, T., Alexandrov, L.B., Larsimont, D., Davies, H., et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat. Med. 21 (2015), 751–759.